1. "Mark Robson"
  2. "Sujata Patil"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (14)
  3. Review (1)
Groups
  1. Biostatistics Service (32)
  2. Breast Medicine Service (32)
  3. Department of Medicine (32)
  4. Epidemiology and Biostatistics (32)
  5. Population Sciences Research Program (32)
  6. Solid Tumor Oncology Division (32)

More Groups

People
  1. Mark Robson (32)
  2. Sujata Patil (32)
  3. Tiffany Traina (12)
  4. Clifford Hudis (11)
  5. Kenneth Offit (8)
  6. Larry Norton (8)

More People

Years
  1. 2022 (1)
  2. 2021 (4)
  3. 2020 (7)
  4. 2019 (2)
  5. 2018 (3)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer (4)
  3. Cancer Research (3)
  4. Breast Cancer Research and Treatment (2)
  5. Cochrane Database of Systematic Reviews (2)
  6. American Journal of Surgical Pathology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (5)
  3. Wiley Blackwell (4)
  4. Springer (3)
  5. Elsevier Inc. (2)
  6. John Wiley & Sons (2)

More Publishers

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing
    Journal Article

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Reisz, P. A.; Lenis, A. T.; Mehta, N. N.; Khurram, A.; Joseph, V.; Mandelker, D.; more...
    European Urology Oncology (2021)

    Fulltext@MSK | Save
  • PD-L1 expression in metaplastic breast carcinoma using the PD-L1 SP142 assay and concordance among PD-L1 immunohistochemical assays
    Journal Article

    Grabenstetter, A.; Jungbluth, A. A.; Frosina, D.; Hoda, R.; Dos Anjos, C. H.; Patil, S.; Sevilimedu, V.; Weigelt, B.; Reis-Filho, J. S.; Zhang, H.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • Early-onset renal cell carcinoma: Assessment of germline genetic testing criteria
    Meeting Abstract

    Sheikh, R.; Truong, H.; Kotecha, R.; Kemel, Y.; Khurram, A.; Vijay, J.; Mandelker, D.; Ceyhan-Birsoy, O.; Latham, A.; Walsh, M.; more...
    Molecular Genetics and Metabolism (2021)

    Fulltext@MSK | Save
  • PARP (poly ADP-ribose polymerase) inhibitors for locally advanced or metastatic breast cancer
    Review

    Taylor, A. M.; Chan, D. L. H.; Tio, M.; Patil, S. M.; Traina, T. A.; Robson, M. E.; Khasraw, M.
    Cochrane Database of Systematic Reviews (2021)

    Fulltext@MSK | Save
  • Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Journal Article

    Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients receiving neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in HER2-positive early breast cancer (BC)
    Meeting Abstract

    Ferraro, E.; Barrio, A. V.; Patil, S.; Robson, M. E.; Dang, C. T.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Disparities in work status after treatment for breast cancer: A controlled, longitudinal study
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Eberle, C.; Jung, G.; Kampel, L. J.; Hwang, C.; Bao, T.; Robson, M. E.; Malik, M.; Gany, F.
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma
    Journal Article

    Hoda, R. S.; Brogi, E.; Dos Anjos, C. H.; Grabenstetter, A.; Ventura, K.; Patil, S.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Traina, T.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
    Meeting Abstract

    Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save